You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 12, March 22, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cerebrovascular Complications of Streptokinase Infusion

Michael S. Aldrich, MD; Steven A. Sherman, MD; Harry S. Greenberg, MD

JAMA. 1985;253(12):1777-1779.


Abstract

Ninety-one patients treated with streptokinase for vascular occlusion were studied retrospectively to document the incidence of cerebral hemorrhage. Three cerebrovascular complications occurred. Two patients had cerebral hemorrhage, one following limb ischemia, the other after acute myocardial infarction. The third patient received streptokinase for an occluded right subclavian bypass graft and suffered a right frontoparietal infarction, presumably secondary to retrograde embolization, but not angiographically proved. This incidence of cerebrovascular complications must be taken within the framework of the baseline incidence following systemic isehemia, but suggests that caution be exercised with this therapy.

(JAMA 1985;253:1777-1779)



Author Affiliations

From the Department of Neurology, University of Michigan Hospitals, Ann Arbor.


Footnotes

Presented in part at the American Academy of Neurology Annual Meeting, Boston, April 11, 1984.

Reprint requests to Department of Neurology, B4913 CFOB, Box M056, University of Michigan Hospitals, Ann Arbor, MI 48109 (Dr Aldrich).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intracranial Hemorrhage as the Synergistic Effect of Urokinase and Renal Dysfunction--A Case Report
Wyble et al.
VASC ENDOVASCULAR SURG 1993;27:395-399.
ABSTRACT  

Thrombolysis in deep venous thrombosis
Pilger et al.
Vasc Med 1990;1:167-178.
 

Ruptured Arteriovenous Malformation Complicating Thrombolytic Therapy With Tissue Plasminogen Activator
Proner et al.
Arch Neurol 1990;47:105-106.
ABSTRACT  

Intracerebral Hemorrhage Complicating Intravenous Tissue Plasminogen Activator Treatment
Carlson et al.
Arch Neurol 1988;45:1070-1073.
ABSTRACT  

Thrombolysis and Stroke: Past and Future
Sloan
Arch Neurol 1987;44:748-768.
ABSTRACT  

Massive Pulmonary Embolism: Short-Term Effects of Thrombolytic Treatment
Grau et al.
ANGIOLOGY 1986;37:832-839.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.